Enfusion, Inc. (ENFN)
Enfusion, Inc. operates in the Software - Application industry of the Technology sector, headquartered in Chicago, IL, US. The stock last traded at $10.76, down 0.37% on the session, giving a market capitalisation of $1.02B. On trailing twelve-month figures it carries a trailing P/E of 572.34, a net margin of 1.4%. Its beta of 0.93 implies it has historically moved less than the broad market.
Enfusion, Inc. supplies cloud-based software solutions designed for the investment management sector, operating throughout the United States, Europe, the Middle East, Africa, and the Asia Pacific. Its product suite includes a sophisticated portfolio management system, which establishes an instant and comprehensive investment record. This system incorporates valuation and risk assessment tools, allowing chief investment officers (CIOs) and portfolio managers to analyze aggregated or granular portfolio data. The company also offers an order and execution management system, enabling portfolio managers, traders, compliance teams, and analysts to electronically transmit and manage trade orders across various asset classes. This system simultaneously enforces trading regulations and internal operational guidelines. Additionally, Enfusion provides an accounting and general ledger system that serves as a real-time financial book of record, vital for chief financial officers (CFOs), chief operating officers (COOs), accountants, and operations teams. Furthermore, the Enfusion analytics system empowers CIOs, portfolio managers, traders, and analysts to scrutinize portfolios over different timeframes and automatically generate customized visual reports for both internal and external stakeholders. Complementing these software offerings, Enfusion also delivers technology-powered and managed services. Enfusion Inc. was founded in 2021 and is headquartered in Chicago, Illinois.
Enfusion, Inc. is most often compared with the following Technology names: